Has Joseph Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $57,348 in general payments to Joseph Lin, MD across 162 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph Lin, MD

Cardiovascular Disease · Minneapolis, MNNPI 1184667248

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 54.7% of the total. Reporting peaked in 2019 at $15,905 and has fallen 64.7% since, to $5,616 in 2025. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,348in general payments, 2019–2025

Across 162 payments — averaging $354.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$31K
Abbott$18K
Boston Scientific$8K
Atricure, Inc.$96
Biotronik Inc.$58
Cardiva Medical, Inc.$29
plus $108 from 6 others

$18,955in research payments, 2019–2025

Across 12 payments — averaging $1579.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$15K
Medtronic$4K

What the payments were for

Consulting fees$21,87538%
Speaking & faculty fees$30,15053%
Travel & lodging$6001%
Food & beverage$4,7238%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	68	$31,345
Abbott	40	$18,057
Boston Scientific	44	$7,654
Atricure, Inc.	1	$96
Biotronik Inc.	2	$58
Cardiva Medical, Inc.	1	$29
Cook Medical LLC	1	$24
Biosense Webster, Inc.	1	$21
Abiomed	1	$18
Philips North America LLC	1	$16
Vertical Pharmaceuticals, LLC	1	$15
Impulse Dynamics (USA) Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EP-WorkMate Claris System$8,736
WATCHMAN Access System$5,126
TACTICATH ABLATION CATHETER, SENSOR ENABLED$4,761
Arctic Front$3,350
Ensite Cardiac Mapping System$2,028
EnSite Precision Cardiac Mapping System$1,652
ENSITE$353
ARCTIC FRONT ADVANCE$247
ACCENT$179
RF Conductr$165
ATTAIN COMMAND + SUREVALVE$151
Farapulse$150
GENERAL EP$146
ENSITE PRECISION$136
PulseSelect$133
WATCHMAN FLX$116
Watchman$107

How this compares

$57,348 in reported general payments places this provider in the 90th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota →

Medicare billing

Part B allowed, 2024

$183,700

Medicare patients

880

Services billed

2,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	101	$111,304
XareltoRivaroxaban	35	$48,346
Metoprolol Succinate	161	$2,735
Flecainide Acetate	73	$2,365
SotalolSotalol Hcl	118	$1,929
Amiodarone Hcl	95	$1,503
Diltiazem 24hr Er (Cd)Diltiazem Hcl	71	$889
ClopidogrelClopidogrel Bisulfate	87	$715
Furosemide	48	$364
Warfarin Sodium	24	$336
Metoprolol Tartrate	22	$325
Atorvastatin Calcium	25	$316
Carvedilol	22	$300
Colchicine	39	$262
Rosuvastatin Calcium	15	$250

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Minneapolis

Jeffrey ChambersMinneapolis$3.2M
Markus MeyerMinneapolis$786K
Robert SchwartzMinneapolis$502K
Robert VantasselMinneapolis$493K
Nedaa SkeikMinneapolis$453K
Joao CavalcanteMinneapolis$384K
Inderjit AnandMinneapolis$384K
David HurrellMinneapolis$205K
Yader Sandoval PichardoMinneapolis$157K
Charles HerzogMinneapolis$157K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →